Treatment of Hypertensive Heart Disease by Targeting Smad3 Signaling in Mice

Transforming growth factor β (TGF-β)/Smad3 signaling plays a central role in chronic heart disease. Here, we report that targeting Smad3 with a Smad3 inhibitor SIS3 in an established mouse model of hypertension significantly improved cardiac dysfunctions by preserving the left ventricle (LV) ejectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Jinxiu, Qin, Yuyan, Chen, Junzhe, Wei, Lihua, Huang, Xiao-ru, Yu, Xiyong, Lan, Hui-yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475647/
https://www.ncbi.nlm.nih.gov/pubmed/32953930
http://dx.doi.org/10.1016/j.omtm.2020.08.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475647/
https://www.ncbi.nlm.nih.gov/pubmed/32953930
http://dx.doi.org/10.1016/j.omtm.2020.08.003

Ejemplares similares